Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Status of Metastatic Bladder Cancer Treatment Illustrated by a Case

Research output: Contribution to journalReviewResearchpeer-review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{32e5dfb8f883454e9863738631b53fd7,
title = "Status of Metastatic Bladder Cancer Treatment Illustrated by a Case",
abstract = "OBJECTIVE: This study aims to provide an overview of current treatment guidelines within the context of metastatic bladder cancer illustrated by a case report.DATA SOURCES: International guidelines from The American Society of Clinical Oncology (ASCO), The European Society of Medical Oncology (ESMO), and scientific references supporting these clinical guidelines. To illustrate the implementation of current evidence-based guidelines a patient case report was presented.CONCLUSION: Historically, there have been limited treatment options available for metastatic bladder cancer for three decades. However, with the introduction of immunotherapy and emergent targeted therapies for metastatic bladder cancer increasing survival rates are expected.IMPLICATIONS FOR NURSING PRACTICE: To achieve improved treatment outcome in people affected by metastatic bladder cancer it is important that both doctors and nurses are aware of contemporary evidence-based treatment options in keeping with ESMO and ASCO international clinical guidelines. Nurses play an important role in educating patients about the potential side effects of therapy and in offering timely, tailored, and supported self-management.",
keywords = "Bladder cancer, Guidelines, Treatment",
author = "Dohn, {Line Hammer} and Omland, {Lise H{\o}j} and Helle Pappot and Stormoen, {Dag Rune}",
note = "Copyright {\textcopyright} 2020 Elsevier Inc. All rights reserved.",
year = "2021",
month = feb,
doi = "10.1016/j.soncn.2020.151113",
language = "English",
volume = "37",
pages = "151113",
journal = "Seminars in Oncology Nursing",
issn = "0749-2081",
publisher = "W.B. Saunders Ltd",
number = "1",

}

RIS

TY - JOUR

T1 - Status of Metastatic Bladder Cancer Treatment Illustrated by a Case

AU - Dohn, Line Hammer

AU - Omland, Lise Høj

AU - Pappot, Helle

AU - Stormoen, Dag Rune

N1 - Copyright © 2020 Elsevier Inc. All rights reserved.

PY - 2021/2

Y1 - 2021/2

N2 - OBJECTIVE: This study aims to provide an overview of current treatment guidelines within the context of metastatic bladder cancer illustrated by a case report.DATA SOURCES: International guidelines from The American Society of Clinical Oncology (ASCO), The European Society of Medical Oncology (ESMO), and scientific references supporting these clinical guidelines. To illustrate the implementation of current evidence-based guidelines a patient case report was presented.CONCLUSION: Historically, there have been limited treatment options available for metastatic bladder cancer for three decades. However, with the introduction of immunotherapy and emergent targeted therapies for metastatic bladder cancer increasing survival rates are expected.IMPLICATIONS FOR NURSING PRACTICE: To achieve improved treatment outcome in people affected by metastatic bladder cancer it is important that both doctors and nurses are aware of contemporary evidence-based treatment options in keeping with ESMO and ASCO international clinical guidelines. Nurses play an important role in educating patients about the potential side effects of therapy and in offering timely, tailored, and supported self-management.

AB - OBJECTIVE: This study aims to provide an overview of current treatment guidelines within the context of metastatic bladder cancer illustrated by a case report.DATA SOURCES: International guidelines from The American Society of Clinical Oncology (ASCO), The European Society of Medical Oncology (ESMO), and scientific references supporting these clinical guidelines. To illustrate the implementation of current evidence-based guidelines a patient case report was presented.CONCLUSION: Historically, there have been limited treatment options available for metastatic bladder cancer for three decades. However, with the introduction of immunotherapy and emergent targeted therapies for metastatic bladder cancer increasing survival rates are expected.IMPLICATIONS FOR NURSING PRACTICE: To achieve improved treatment outcome in people affected by metastatic bladder cancer it is important that both doctors and nurses are aware of contemporary evidence-based treatment options in keeping with ESMO and ASCO international clinical guidelines. Nurses play an important role in educating patients about the potential side effects of therapy and in offering timely, tailored, and supported self-management.

KW - Bladder cancer

KW - Guidelines

KW - Treatment

U2 - 10.1016/j.soncn.2020.151113

DO - 10.1016/j.soncn.2020.151113

M3 - Review

C2 - 33422366

VL - 37

SP - 151113

JO - Seminars in Oncology Nursing

JF - Seminars in Oncology Nursing

SN - 0749-2081

IS - 1

ER -

ID: 61759113